A new pilot project led by McGill University researchers is showing early success in helping cancer survivors return to work, addressing an aspect of recovery they say is often overlooked.

iCanWork is an online support program being developed by Christine Maheu, Associate Professor at McGill’s Ingram School of Nursing, in collaboration with BC Cancer.

1 in 3 cancer patients may experience serious cardiovascular side effects from treatment. The European Society of Cardiology (ESC), through its Council of Cardio-Oncology is launching a dedicated conference to focus on the growing epidemic. Taking place on 20 and 21 June in Florence, Italy, the conference will emphasise multidisciplinary collaboration. Highlights include joint sessions with related organisations, as well as interactive workshops, and case-based sessions. 

A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.

CLEVELAND, Ohio (June 11, 2025)—Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide personalized treatment to formulate preventive measures for various diseases. Through a new study, a nomogram was developed and validated to predict the risk of patients with epithelial ovarian cancer developing deep vein thrombosis. Results of the study are published online today in Menopause, the journal of The Menopause Society.